Outcome of Board Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 2015, inter alia, has considered and approved the following matters:- Appointment of Mr. Pardeep Khanna as Chief Financial Officer (CFO) of the Company in place of Mr. Rakesh Mahajan. The Company is enhancing the role of Mr. Rakesh Mahajan with higher responsibilities. Financial Results & Limited Review Report for June 30, 2015 (Standalone)
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30,2015. Outcome of the Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on August 05, 2015, has allotted 5,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval.... Closure of Trading Window
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled to be held on August 13, 2015, inter alia, to consider and approve the un-audited financial results of the Company for the quarter ended June 30, 2015.Further, in terms of provisions of the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the "Trading Window" of the Company shall remain closed from August... IOL Chemicals gets US FDA nod for Ibuprofen facility
With this, IOLCP will be able to garner additional business for its flagship API Ibuprofen in USA, world's largest pharma market IOL Chemicals and Pharmaceuticals Limited going to launch API business to US Market
IOL Chemicals & Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 20, 2015 titled "IOL Chemicals and Pharmaceuticals Limited going to launch API business to US Market". Updates
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Company proposes to make three applications to the Central Government for its approval under Section 196, 197, 203, Schedule V and other applicable provisions of the Companies Act, 2013 for increase in Remuneration, Appointment and Reappointment of Directors/KMP.In this regard the Company has submitted copies of newspaper clipping published on July 13, 2015. Shareholding Pattern For June 30, 2015
IOL Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Innova Marchantiles Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Outcome of Allotment Committee Meeting
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors in its meeting held on July 03, 2015 has allotted 5,00,000 equity shares of Rs. 10/- each to M/s. Innova Marchantiles Limited, Non-Promoter on the exercise of option attached with the warrants allotted on July 04, 2014 and the said shares shall be remain locked in for a period of one year from the date of trading approval....